AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Ponten, F Lindman, H Bostrom, A Berne, B Bergh, J
Citation: F. Ponten et al., Induction of p53 expression in skin by radiotherapy and UV radiation: A randomized study, J NAT CANC, 93(2), 2001, pp. 128-133

Authors: Weis, J Ciray, I Ericsson, A Lindman, H Astrom, G Ahlstrom, H Hemmingsson, A
Citation: J. Weis et al., Spectroscopic imaging of bone marrow composition in vertebral bodies, MAGN RES MA, 13(1), 2001, pp. 15-18

Authors: Ciray, I Lindman, H Astrom, KGO Bergh, J Ahlstrom, KH
Citation: I. Ciray et al., Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging, ACT RADIOL, 42(2), 2001, pp. 198-206

Authors: Bostrom, A Lindman, H Swartling, C Berne, B Bergh, J
Citation: A. Bostrom et al., Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study, RADIOTH ONC, 59(3), 2001, pp. 257-265

Authors: Lindman, H Jansson, T Arnberg, H Bergh, J Einarsson, R
Citation: H. Lindman et al., Serum markers TPS, TPA and CA 15-3 as monitors of chemotherapy in patientswith metastatic breast cancer, J TUMOR M, 15(3), 2000, pp. 177-186

Authors: Lindahl, T Engel, G Ahlgren, J Klaar, S Bjohle, J Lindman, H Andersson, J von Schoultz, E Bergh, J
Citation: T. Lindahl et al., Can axillary dissection be avoided by improved molecular biological diagnosis?, ACTA ONCOL, 39(3), 2000, pp. 319-326

Authors: Einarsson, R Lindman, H Bergh, J
Citation: R. Einarsson et al., Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients, ANTICANC R, 20(6D), 2000, pp. 5089-5093

Authors: Bergh, J Wiklund, T Erikstein, B Lidbrink, E Lindman, H Malmstrom, P Kellokumpu-Lehtinen, P Bengtsson, NO Soderlund, G Anker, G Wist, E Ottosson, S Salminen, E Ljungman, P Holte, H Nilsson, J Blomqvist, C Wilking, N
Citation: J. Bergh et al., Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial, LANCET, 356(9239), 2000, pp. 1384-1391

Authors: Lindman, H Wiklund, T Holte, H Ljungman, P Blomqvist, C Kvalheim, G Bengtsson, M Hoglund, M Wilking, N Bergh, J
Citation: H. Lindman et al., FEC mobilized stem cells for high-dose therapy in breast cancer patients, ACTA ONCOL, 38(2), 1999, pp. 239-245
Risultati: 1-9 |